Zechen Yan
No. 1 Jianshe East Road
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials.
Journal: European urology
Published: May 20, 2026
Re: Hayne D, Zhang AY, Thomas H, et al. Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin-naïve Non-muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.01.009.
Journal: European urology focus
Published: April 19, 2026
Toward personalized management of metastatic PPGL: decoding the implications of the 177Lu-DOTATATE Phase II interim analysis.
Journal: International journal of surgery (London, England)
Published: February 02, 2026
Re: Heidi Fettke, Louise Kostos, Maria Docanto, et al. Baseline and Early On-treatment Circulating Tumour DNA Fraction Are a Key Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated with [177Lu]Lu-PSMA-617. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.015.
Journal: European urology focus
Published: November 13, 2025
Commentary on "The regulatory role and mechanism of TGFBI on tregs in the immune microenvironment of clear cell renal cell carcinoma".
Journal: International journal of surgery (London, England)
Published: November 04, 2025
Comments on "Integrated transcriptomic analysis identifies MZT2A as a prognostic and immune-related biomarker in KIRC".
Journal: International journal of surgery (London, England)
Published: November 04, 2025
Commentary on "Association between prophylactic antibiotics and post-ablation infections in renal cell carcinoma patients: a retrospective multicenter cohort study".
Journal: International journal of surgery (London, England)
Published: November 04, 2025
Comments on "Epigenetic modification of Castor zinc finger 1 (CASZ1) is associated with tumor microenvironments and prognosis of clear cell renal cell carcinoma".
Journal: International journal of surgery (London, England)
Published: October 30, 2025
Unveiling prognostic biomarkers and immunotherapeutic insights in prostate cancer through multi-omics and machine learning.
Journal: European journal of medical research
Published: August 01, 2025
Dietary factors causally affect the risk of kidney cancer: a two-sample Mendelian randomization study.
Journal: Discover oncology
Published: February 25, 2025
WSGC@FA@PEG/PEI-SPIONs Mitigate Chemoresistance in Gastric Adenocarcinoma by Modulating the Notch Signaling Pathway and Mitophagy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 27, 2024
Enhancing doxorubicin sensitivity in osteosarcoma via iRGD-modified biomimetic nanoparticles targeting MCAM m6A modification.
Journal: Journal of translational medicine
Published: October 31, 2024
Last Updated: 09/26/2026